ArticleFoodborne pathogens and disease2025
Global Impact of COVID-19 Pandemic on Gastrointestinal Infections: A Scoping Review.
Article in Foodborne pathogens and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Transmission pathways and risk factors for sporadic salmonellosis and campylobacteriosis: a source attribution meta-analysis of European case-control studies.Epidemiology and infection · 2025Pooled it
- Global distribution and genomic characteristics ofInfectious medicine · 2026Article
- Article
- Kudoa septempunctata Parasite-Associated Foodborne Disease Outbreaks, South Korea, 2015-2024.Emerging infectious diseases · 2026Article
- Molecular Epidemiology of Human Adenovirus Strains in Children With Acute Gastroenteritis in Tehran, Iran (2021-2022 and 2023-2024): Genetic Characterization of Adenovirus F41.Health science reports · 2026Article
- Post-pandemic immunity debt for paediatric infectious diseases in Japan between 2014 and 2024.Epidemiology and infection · 2026Observational
- Phylogenetic Analyses ofMicroorganisms · 2026Article
- Temporal trends in respiratory and gastrointestinal infections at the Grand Magal of Touba: the effect of the COVID-19 pandemic.New microbes and new infections · 2026Article
- The increased detection of recombinant norovirus GII.4 Sydney_2012[P16] strains in hospitalized pediatric patients with gastroenteritis in Shanghai, China.BMC infectious diseases · 2026Article
- Impact of nonpharmaceutical interventions on infectious disease patterns in Yunnan Province across the COVID-19 pandemic phases.BMC infectious diseases · 2026Article
- Global burden of diarrheal diseases attributable to 13 pathogens in children under five: a comprehensive analysis from GBD 2021.Frontiers in pediatrics · 2026Article
- Epidemiological characteristics and spatial clustering analysis of typhoid and paratyphoid fevers in China, 2014-2022.BMC infectious diseases · 2025Article
- The Eat-Out-to-Help-Out incentive: A trigger for gastrointestinal infections in England, 2020?Epidemiology and infection · 2025Article
- Rotavirus Genotype Dynamics and the Emergence of G3P[8] in Thailand Following Nationwide Vaccine Implementation.International journal of molecular sciences · 2025Article
- Shiga toxin-producingFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the COVID-19 pandemic, nonpharmaceutical public health interventions (NPIs) were implemented worldwide to control the spread of severe acute respiratory syndrome coronavirus 2. However, the incidence of other pathogens, including gastrointestinal (GI) pathogens, was also affected. Here, we reviewed studies assessing the impact of NPIs during the COVID-19 pandemic on the incidence of GI infections, particularly foodborne infections. A systems literature search was conducted in May 2023, using Living Evidence on COVID-19 (COAP) and Scopus. Articles were identified and selected through a screening process with inclusion and exclusion criteria based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement. Data were extracted from each full-text article included in the review. Parameters included were GI viruses, GI bacteria, NPIs against the COVID-19 pandemic, and the associated impact of NPIs on GI pathogens. A total of 42 articles were included in the review, representing 18 countries. Overall, a larger reduction was observed for viral GI infections compared with bacterial GI infections during the COVID-19 pandemic, particularly for norovirus. For bacterial GI infections,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.